Dengue Literature Review

Viraemia

3 min read

Viraemia

Overview

Dengue viraemia refers to the presence of circulating dengue virus (virions, viral RNA, and/or the secreted NS1 glycoprotein) in the peripheral blood during the acute phase of infection. The viraemic window defines the period during which: (a) patients are infectious to mosquitoes, (b) virological diagnostic tests can detect infection, and (c) antibody-dependent enhancement (ADE) of viral uptake is possible. Viraemia levels correlate with clinical severity and are a key determinant of diagnostic test performance.

Key Points from Literature

Timing

  • DENV viraemia is detectable 24–48 hours before fever onset and continues for approximately 5–6 days after onset (see Guzman2016 - Dengue Infection)
  • During viraemia, infective virus, DENV-specific RNA, and sNS1 are all detectable in blood, serum, and plasma
  • Viraemia resolves before the onset of peak vascular permeability in DHF, which occurs at defervescence — indicating that plasma leakage is not directly caused by peak viral load but by factors (including sNS1) that accumulate during viraemia and surpass a threshold at fever resolution

Diagnostic significance

  • RT-PCR: detects viral RNA from the start of viraemia; most sensitive during the first 5 days of illness; reference laboratory method
  • NS1 Antigen Detection: sNS1 detectable from day 1 of symptoms through days 5–9; allows early diagnosis; sensitivity/specificity depend on infecting serotype, timing, and primary vs secondary infection status
  • IgM-IgG Serology ELISA: IgM appears from day 5–6 of illness (after viraemia peaks); the gap between viraemia onset and IgM appearance is the “diagnostic window” where only RT-PCR and NS1 detection are useful
  • Viraemia detected by qRT-PCR was the definitional criterion for asymptomatic dengue in the Sungnak2025 Thailand cohort — the strictest available asymptomatic definition (see Asymptomatic Dengue Infection)

Correlation with severity

  • sNS1 blood levels correlate with peak viraemia and with disease severity specifically in secondary DENV infection (see Guzman2016 - Dengue Infection)
  • High viraemia is listed as a biomarker under evaluation for dengue prognosis, but none have been approved for routine practice
  • Asymptomatic dengue donors in Sungnak2025 were confirmed viremic (detectable DENV RNA) while showing no clinical symptoms — establishing that viraemia per se does not necessitate symptomatic illness; host immune response determines clinical outcome (see Sungnak2025 - Distinct Immune Responses Asymptomatic Symptomatic Dengue)

Role in transmission

  • Both symptomatic and asymptomatic viraemic individuals can transmit DENV to feeding Ae. aegypti mosquitoes (see Guzman2016 - Dengue Infection)
  • The intrinsic incubation period (infection to fever onset) is 3–14 days (average 4–7 days); the extrinsic incubation period in the mosquito (blood meal to infective salivary glands) is 5–12 days (generally 8–10 days)

Contradictions & Debates

  • The relationship between viraemia level and ADE-mediated severe disease is not straightforward: higher viraemia is a correlate but not a direct cause of DHF; it may reflect greater viral uptake via ADE rather than cause it.
  • sNS1 levels correlate with severity in secondary but not clearly in primary infection, suggesting that antibody-NS1 interactions (or the ADE-amplified infection state) modulate sNS1 diagnostic performance.

Sources

Graph View

Backlinks